Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;3(1):1-12.
doi: 10.4297/najms.2011.31.

Pancreatic cancer: chemotherapy and radiotherapy

Ake Andrén-Sandberg  1
Affiliations

Pancreatic cancer: chemotherapy and radiotherapy

Ake Andrén-Sandberg. N Am J Med Sci. 2011 Jan.

Abstract

Pancreatic cancer in many cases appears in a non-curatively resectable stage when the diagnosis is made. Palliative treatment become an option in the patients with advanced stage. The present article reviewed chemotherapy and radiotherapy in various advanced stage of pancreatic cancer.

Keywords: Pancreas; adjuvant; chemotherapy; pancreatic cancer; radiotherapy.

PubMed Disclaimer

References

    1. Sahora K, Kuehrer I, Eisenhut A, et al. NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer. Surgery. 2010 Sep 2; [Epub ahead of print] - PubMed
    1. da Cunha Santos G, Dhani N, Tu D, et al. Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: national Cancer Institute of Canada Clinical Trials Group Study PA.3. Cancer. 2010 Sep 7; (Epub ahead of print] - PubMed
    1. Katz MH, Merchant NB, Brower S, et al. The American College of Surgeons Oncology Group.Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg. 2010 Sep 1; [Epub ahead of print] - PMC - PubMed
    1. Richards NG, Rittenhouse DW, Freydin B, et al. HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients. Ann Surg. 2010;252:499–505. - PubMed
    1. Ogawa K, Karasawa K, Ito Y, et al. JROSG Working Subgroup of Gastrointestinal Cancers.Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys. 2010;77:734–742. - PubMed